CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Assets
Cash and due from banks	$ 7,624	$ 12,716
Interest bearing deposits with banks	163,469	167,660
Cash and cash equivalents	171,093	180,376
Investment securities available for sale, at fair value	6,640	7,095
Investment securities held to maturity, net of allowance for credit losses of $0 at March 31, 2024 and December 31, 2023 (fair value of $7,685 at March 31, 2024 and $7,892 at December 31, 2023)	9,271	9,292
Total investment securities	15,911	16,387
Loans, net of unearned income	1,785,542	1,787,340
Less: Allowance for credit losses	(31,918)	(32,131)
Net loans	1,753,624	1,755,209
Accrued interest receivable	8,865	8,555
Premises and equipment, net	5,501	5,579
Restricted stock	6,298	7,636
Bank owned life insurance (BOLI)	28,575	28,415
Deferred tax asset	9,271	9,262
Other real estate owned (OREO)	1,550	1,550
Other	8,385	10,531
Total assets	2,009,073	2,023,500
Deposits
Noninterest-bearing deposits	196,388	232,189
Interest-bearing deposits	1,367,316	1,320,638
Total deposits	1,563,704	1,552,827
FHLBNY borrowings	95,000	125,000
Subordinated debentures	43,158	43,111
Accrued interest payable	4,398	4,146
Other	14,427	14,099
Total liabilities	1,720,687	1,739,183
Shareholders' Equity
Preferred stock, 1,000,000 shares authorized, $1,000 liquidation value Series B non-cumulative convertible; 375 shares outstanding at March 31, 2024 and December 31, 2023	375	375
Common stock, $0.10 par value; authorized 15,000,000 shares; Issued: 12,247,343 shares and 12,240,821 shares at March 31, 2024 and December 31, 2023, respectively	1,225	1,224
Additional paid-in capital	136,801	136,700
Retained earnings	153,430	149,437
Accumulated other comprehensive loss	(430)	(404)
Treasury stock, 284,522 shares at March 31, 2024 and December 31, 2023, at cost	(3,015)	(3,015)
Total shareholders’ equity	288,386	284,317
Total liabilities and shareholders' equity	$ 2,009,073	$ 2,023,500